1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Coronary Guidewires Overview
3 Products under Development
3.1 Coronary Guidewires - Pipeline Products by Stage of Development
3.2 Coronary Guidewires - Pipeline Products by Territory
3.3 Coronary Guidewires - Pipeline Products by Regulatory Path
3.4 Coronary Guidewires - Pipeline Products by Estimated Approval Date
3.5 Coronary Guidewires - Ongoing Clinical Trials
4 Coronary Guidewires - Pipeline Products under Development by Companies
4.1 Coronary Guidewires Companies - Pipeline Products by Stage of Development
4.2 Coronary Guidewires - Pipeline Products by Stage of Development
5 Coronary Guidewires Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 APT Medical Inc Company Overview
5.2.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Bioscan Technologies Inc. Company Overview
5.3.1 Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Boston Scientific Corp Company Overview
5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cardiovascular Systems Inc Company Overview
5.5.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 CorMetrics LLC Company Overview
5.6.1 CorMetrics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 Echopoint Medical Ltd Company Overview
5.7.1 Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 ENDOMATERIALS Company Overview
5.8.1 ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview
5.9 Georgia Institute of Technology Company Overview
5.9.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.10 Guided Interventions, LLC Company Overview
5.10.1 Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Infrared Sciences Corp Company Overview
5.11.1 Infrared Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.12 Koninklijke Philips NV Company Overview
5.12.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview
5.13 MaRVis Technologies GmbH Company Overview
5.13.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.14 Microbot Medical Ltd Company Overview
5.14.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 MicroPort Scientific Corp Company Overview
5.15.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.16 NewMed Medical Co Ltd Company Overview
5.16.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Nirtek Pty Ltd Company Overview
5.17.1 Nirtek Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.18 Opsens Inc Company Overview
5.18.1 Opsens Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 OVALUM Ltd Company Overview
5.19.1 OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 SoundBite Medical Solutions Inc Company Overview
5.20.1 SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 St. Jude Medical LLC Company Overview
5.21.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.22 Terumo Corp Company Overview
5.22.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.23 Terumo Interventional Systems Company Overview
5.23.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
5.24 The Cleveland Clinic Foundation Company Overview
5.24.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview
5.25 Three Rivers Cardiovascular Systems Inc Company Overview
5.25.1 Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Transmural systems LLC Company Overview
5.26.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview
5.27 University of Illinois at Chicago Company Overview
5.27.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.28 Vasostar Ltd. Company Overview
5.28.1 Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview
6 Coronary Guidewires- Recent Developments
6.1 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
6.2 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
6.3 Feb 14, 2023: Asahi Intecc Announces Consolidated Financial Results for the Six Months Ended December 31, 2022
6.4 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
6.5 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
6.6 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
6.7 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president
6.8 Jan 12, 2023: OpSens Announces Record First Quarter fiscal 2023 Financial Results
6.9 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
6.10 Nov 23, 2022: Medtronic Reports Quarterly Earnings
6.11 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
6.12 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
6.13 Nov 11, 2022: Asahi Intecc Consolidated Financial Results for the Three Months Ended September 30, 2022
6.14 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022
6.15 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
6.16 Sep 07, 2022: Medtronic to appear at September investor conferences
6.17 Sep 06, 2022: Occlutech Appoints Chief Commercial Officer and Vice President Global Business Development & Marketing
6.18 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
6.19 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
6.20 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
6.21 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022
6.22 Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
6.23 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
6.24 Jul 14, 2022: Opsens Announces Third Quarter Fiscal 2022 Financial Results With Record Quarterly Revenues
6.25 Jul 12, 2022: Opsens Set to Announce Earnings on Thursday
6.26 Jul 08, 2022: Cordis Names Bryan Loo President of Asia-pacific Region
6.27 Jul 07, 2022: Opsens to Host Third Quarter Fiscal Year 2022 Financial Results Conference Call on Thursday, July 14
6.28 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
6.29 Jun 23, 2022: Cleveland Clinic Appoints Alex A. Adjei, M.D., Ph.D., as Chair of Taussig Cancer Institute
6.30 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
6.31 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
6.32 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
6.33 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022
6.34 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022
6.35 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
